palmitoyl prednisolone

Known as: Pal-PLS 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2010
01220042010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Four-way data were obtained by recording the kinetic evolution of excitation-emission fluorescence matrices for samples… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2009
2009
BACKGROUND The methicillin-resistant Staphylococcus aureus (MRSA) surface protein Pls (plasmin sensitive) reduces adhesion to… (More)
  • figure 1
  • figure 4
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
2008
2008
Reversible posterior leukoencephalopathy syndrome (PLS) is characterized by headache, clouding of sensorium, visual disturbances… (More)
Is this relevant?
2006
2006
We compared the pharmacokinetic behavior of drugs after an intravenous administration of prednisolone (PLS), palmitoyl… (More)
Is this relevant?
2006
2006
We investigated the pharmacokinetic behavior of palmitoyl prednisolone (Pal-PLS) and its liposomes with L-alpha… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
2004
2004
The purpose of this study is to demonstrate a stable retention of prednisolone (PLS) in the unique liposomes integrated by… (More)
Is this relevant?